In situ gelling drug delivery systems for topical drug delivery
- PMID: 36642283
- DOI: 10.1016/j.ejpb.2023.01.007
In situ gelling drug delivery systems for topical drug delivery
Abstract
In situ gelling formulations are drug delivery systems which typically exist in a liquid form at room temperature and change into gel state after application to the body in response to various stimuli such as changes in temperature, pH and ionic composition. Their biomedical application can further be improved by incorporating drug nanoparticles into in situ gelling systems in order to prolong drug release, reduce dosing frequency and improve therapeutic outcomes of patients, developing highly functional but challenging dosage forms. The composition of in situ gelling formulations influence factors relating to performance such as their syringeability, rheology, drug release profile and drug bioavailability at target sites, amongst other factors. The inclusion of mucoadhesive polymeric constituents into in situ gelling formulations has also been explored to ensure that the therapeutic agents are retained at target site for extended period of time. This review article will discuss traditional techniques (water bath-based vial inversion and viscometry) as well as advanced methodology (rheometry, differential scanning calorimetry, Small Angle Neutron Scattering, Small Angle X-ray Scattering, etc.) for evaluating in situ gel forming systems for topical drug delivery. The clinical properties of in situ gelling systems that have been studied for potential biomedical applications over the last ten years will be reviewed to highlight current knowledge in the performance of these systems. Formulation issues that have slowed the translation of some promising drug formulations from the research laboratory to the clinic will also be detailed.
Keywords: Drug delivery; In situ gelling formulations; Rheometry; SAXS/SANS; Stimuli-responsive; Viscometry.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6. Int J Pharm. 2020. PMID: 31705970
-
Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.Eur J Pharm Biopharm. 2020 Sep;154:1-7. doi: 10.1016/j.ejpb.2020.06.016. Epub 2020 Jun 27. Eur J Pharm Biopharm. 2020. PMID: 32599271
-
In Situ Forming Depot as Sustained-Release Drug Delivery Systems.Crit Rev Ther Drug Carrier Syst. 2019;36(2):93-136. doi: 10.1615/CritRevTherDrugCarrierSyst.2018025013. Crit Rev Ther Drug Carrier Syst. 2019. PMID: 30806210 Review.
-
Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.Expert Opin Drug Deliv. 2020 Apr;17(4):495-509. doi: 10.1080/17425247.2020.1731469. Epub 2020 Feb 23. Expert Opin Drug Deliv. 2020. PMID: 32067500 Review.
-
Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.Pharmaceutics. 2020 Sep 10;12(9):859. doi: 10.3390/pharmaceutics12090859. Pharmaceutics. 2020. PMID: 32927595 Free PMC article. Review.
Cited by
-
Diatom-guided bone healing via a hybrid natural scaffold.Heliyon. 2024 Feb 11;10(4):e25878. doi: 10.1016/j.heliyon.2024.e25878. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38384564 Free PMC article.
-
Phase-Inversion In Situ Systems: Problems and Prospects of Biomedical Application.Pharmaceutics. 2025 Jun 6;17(6):750. doi: 10.3390/pharmaceutics17060750. Pharmaceutics. 2025. PMID: 40574062 Free PMC article. Review.
-
[Research progress of methylcellulose-based thermosensitive hydrogels applied in biomedical field].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024 Feb 25;41(1):199-204. doi: 10.7507/1001-5515.202303022. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024. PMID: 38403622 Free PMC article. Chinese.
-
A New Hyaluronic Emulgel of Hesperetin for Topical Application-An In Vitro Evaluation.J Funct Biomater. 2024 Apr 1;15(4):89. doi: 10.3390/jfb15040089. J Funct Biomater. 2024. PMID: 38667546 Free PMC article.
-
Thermosensitive Polyurethane-Based Hydrogels as Potential Vehicles for Meloxicam Delivery.Pharmaceuticals (Basel). 2023 Oct 24;16(11):1510. doi: 10.3390/ph16111510. Pharmaceuticals (Basel). 2023. PMID: 38004376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources